Literature DB >> 16445580

Hypoxia-reoxygenation-induced apoptosis in cultured neonatal rat cardiomyocyets and the protective effect of prostaglandin E.

Xiang-Qin Ma1, Run-Fang Fu, Guo-Qing Feng, Zhen-Ji Wang, Shou-Guo Ma, Shi-Ai Weng.   

Abstract

The aim of the present study was to investigate the effect of prostaglandin (PG) E1 on hypoxia/re-oxygenation (H/R) apoptosis and the expression of bcl-2 and bax in cultured neonatal rat cardiomyocytes. The H/R model was made using the first generation of cultured neonatal rat cardiomyocytes. Hypoxia/re-oxygenation apoptosis was studied by electron microscopy and agarose gel electrophoresis. The percentage of apoptotic cells was measured by terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end-labeling (TUNEL). The expression of bcl-2 and bax was detected by in situ hybridization and immunohistochemical staining. Most cells of the H/R group tested by electron microscopy showed cytoplasmic concentration, nuclear chromatin condensation and margination. Prostaglandin E1 (5, 15 and 45 microg/L) relieved the injury. The results of DNA electrophoresis in the H/R group showed a typical DNA ladder and the DNA ladder decreased gradually corresponding with increasing doses of PGE1. The TUNEL staining showed that the total number of apoptotic cells in the H/R group was much more than that in the PGE1 (45 microg/L) group. The results of in situ hybridization and immunohistochemical staining showed that the bcl-2 content in the H/R group was lower than that in the control group; bax content showed the reverse. Compared with the H/R group, bcl-2 content was significantly higher in the PGE1 (5, 15 and 45 microg/L) groups. However, bax content in the PGE1 (5, 15 and 45 microg/L) groups was significantly lower than that in the H/R group. 6. In conclusion, H/R injury can induce cardiomyocyte apoptosis. Prostaglandin E1 obviously has anti-apoptotic effects on cardiomyocytes and the mechanisms probably involve the inhibition of bax expression and increased expression of bcl-2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16445580     DOI: 10.1111/j.1440-1681.2005.04311.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  6 in total

1.  Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-beta.

Authors:  Haipeng Sun; Elena Sheveleva; Beibei Xu; Hiroyasu Inoue; Tim G Bowden; Qin M Chen
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-23       Impact factor: 4.249

2.  LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism.

Authors:  Haipeng Sun; Beibei Xu; Elena Sheveleva; Qin M Chen
Journal:  Toxicol Appl Pharmacol       Date:  2008-06-04       Impact factor: 4.219

3.  Resveratrol alleviates hypoxia/reoxygenation injury‑induced mitochondrial oxidative stress in cardiomyocytes.

Authors:  Tao Li; Linlin Chen; Yiyan Yu; Binbin Yang; Pengyun Li; Xiao-Qiu Tan
Journal:  Mol Med Rep       Date:  2019-02-07       Impact factor: 2.952

4.  Prostaglandin E₁ protects bone marrow-derived mesenchymal stem cells against serum deprivation-induced apoptosis.

Authors:  Kuan Zeng; Bao Ping Deng; Hui-Qi Jiang; Meng Wang; Ping Hua; Hong-Wu Zhang; Yu-Bin Deng; Yan-Qi Yang
Journal:  Mol Med Rep       Date:  2015-08-05       Impact factor: 2.952

5.  Protective Effect and Mechanism of Alprostadil in Acute Respiratory Distress Syndrome Induced by Oleic Acid in Rats.

Authors:  Xiujuan Yan; Yingxiu Li; Yun Ho Choi; Chongyang Wang; Yihua Piao; Jing Ye; Jingzhi Jiang; Liangchang Li; Huixian Xu; Qingsong Cui; Guanghai Yan; Minggen Jin
Journal:  Med Sci Monit       Date:  2018-10-08

6.  Prostaglandin E1 protects cardiomyocytes against hypoxia-reperfusion induced injury via the miR-21-5p/FASLG axis.

Authors:  Mingxiang Tang; Hongwei Pan; Zhaofen Zheng; Yin Guo; Jianqiang Peng; Jun Yang; Yangping Luo; Jin He; Sulan Yan; Peng Wang; Yi Zhang; Yulu Zhou
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.